Work

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Year: 2014

Type: article

Study design: Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-014-3008-5

Authors: Yifan Tu, Dawn L. Hershman, Kapil Bhalla, Warren Fiskus, Christine M. Pellegrino, Eleni Andreopoulou, Della Makower, Kevin Kalinsky, Karen Fehn, Susan Fineberg, Abdissa Negassa, Leslie L. Montgomery, Lisa S. Wiechmann, R. Katherine Alpaugh, Min Huang, Joseph A. Sparano

Institutions: Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Columbia University, Houston Methodist, Albert Einstein College of Medicine, Fox Chase Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, National Cancer Institute

Award: G227925980

OpenAlex ID: W2013344605

FWCI: 1.947

Cites: 22

Cited by: 59

Related to: 10